Glasgow-Blatchford Bleeding Score
Stratification of upper gastrointestinal bleeding patients
Další informace
Upozornění
Tento nástroj slouží pouze pro vzdělávací účely a nepředstavuje odborné poradenství ani odborné poradenství nenahrazuje. Tento nástroj není určen k lékařské diagnostice nebo léčbě.
General description
Acute upper-gastrointestinal bleeding is a common reason for emergency hospital admissions worldwide. Several systems have been designed to stratify these patients into different risk categories for adverse outcomes. Glasgow-Blatchford Bleeding Score (GBS) was developed to assess whether patients presenting with acute upper-gastrointestinal bleeding will likely require hospital admission to manage their bleeding.
GBS uses a scoring system based on routinely available clinical and laboratory data to identify patients with very low risk of rebleeding or needing hospital-based interventions that can be safely managed as outpatients.
GBS is endorsed by the 2021 European Society of Gastrointestinal Endoscopy (ESGE) Guideline for endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage.
Acute upper-gastrointestinal bleeding is a common reason for emergency hospital admissions worldwide. Several systems have been designed to stratify these patients into different risk categories for adverse outcomes. Glasgow-Blatchford Bleeding Score (GBS) was developed to assess whether patients presenting with acute upper-gastrointestinal bleeding will likely require hospital admission to manage their bleeding.
GBS uses a scoring system based on routinely available clinical and laboratory data to identify patients with very low risk of rebleeding or needing hospital-based interventions that can be safely managed as outpatients.
GBS is endorsed by the 2021 European Society of Gastrointestinal Endoscopy (ESGE) Guideline for endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage.
Result ranges
Very low risk of rebleeding, outpatient management generally recommended
≤ 1Inpatient management should be considered
≥ 2Formula
Presentation with melena, pulse ≥ 100 bpm, systolic blood pressure 100–109 mmHg, haemoglobin ≥ 100 and < 120 g/L for women and haemoglobin ≥ 120 and < 130 g/L for men are given 1 point.
Presentation with syncope, hepatic disease, cardiac disease, systolic blood pressure 90–99 mmHg and blood urea ≥ 6.5 and < 8.0 mmol/L are given 2 points.
Systolic blood pressure < 90 mmHg, haemoglobin ≥ 100 and < 120 g/L for men and blood urea ≥ 8.0 and < 10.0 mmol/L are given 3 points.
Blood urea ≥ 10.0 and < 25.0 mmol/ is given 4 points.
Haemoglobin < 100 g/L for men and women and blood urea ≥ 25.0 mmol/L are given 6 points.
Presentation with syncope, hepatic disease, cardiac disease, systolic blood pressure 90–99 mmHg and blood urea ≥ 6.5 and < 8.0 mmol/L are given 2 points.
Systolic blood pressure < 90 mmHg, haemoglobin ≥ 100 and < 120 g/L for men and blood urea ≥ 8.0 and < 10.0 mmol/L are given 3 points.
Blood urea ≥ 10.0 and < 25.0 mmol/ is given 4 points.
Haemoglobin < 100 g/L for men and women and blood urea ≥ 25.0 mmol/L are given 6 points.
References
Blatchford, O et al. “A risk score to predict need for treatment for upper-gastrointestinal haemorrhage.” Lancet (London, England) vol. 356,9238 (2000): 1318-21. doi:10.1016/S0140-6736(00)02816-6
Gralnek, Ian M et al. “Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021.” Endoscopy vol. 53,3 (2021): 300-332. doi:10.1055/a-1369-5274
Verze
1
O tomto nástroji
Acute upper-gastrointestinal bleeding is a common reason for emergency hospital admissions worldwide. Several systems have been designed to stratify these patients into different risk categories for adverse outcomes. Glasgow-Blatchford Bleeding Score (GBS) was developed to assess whether patients presenting with acute upper-gastrointestinal bleeding will likely require hospital admission to manage their bleeding.
GBS uses a scoring system based on routinely available clinical and laboratory data to identify patients with very low risk of rebleeding or needing hospital-based interventions that can be safely managed as outpatients.
GBS is endorsed by the 2021 European Society of Gastrointestinal Endoscopy (ESGE) Guideline for endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage.
GBS uses a scoring system based on routinely available clinical and laboratory data to identify patients with very low risk of rebleeding or needing hospital-based interventions that can be safely managed as outpatients.
GBS is endorsed by the 2021 European Society of Gastrointestinal Endoscopy (ESGE) Guideline for endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage.
